The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
yes...yr probably right
Surgical Innovations has swung to an H1 pretax loss of £3.2m, from a profit of £0.57m. Revenue was £1.8m, from £3.9m.
The Company's Non-executive Directors have also unanimously agreed to waive their entitlements to receive any fees or other remuneration in respect of any services they provide to the Company after the date of this announcement until further notice as the Company focuses on cost savings and cash generation.
but unlikely of course
Directorate Change The Board of Surgical Innovations (AIM:SUN) announces the departure of Graham Bowland as the Company's Chief Executive Officer with immediate effect. Chief Financial Officer Mike Thornton has been appointed as the Company's Interim Chief Executive Officer.
so selling will probably take us sub 2p ...c1.5p for loading up ...opinion only
don't give up, Modsa lol
Perhaps Mr. Rea can persuade DL to leave the running of the company to the CEO. We really need to get away from the overreliance on the USA. My mistake I should have sold.
I bought back in (30k this morning sub 2.5p) on hope for bounce and for change in management focus (encouraged by narrative in rns...and expect Mr Rea to play a v positive role) ...will look to load up sub tnw/2p if we get there
is awful...they spend so much on intangibles ...and then highlight ebitda lol ...I focus(ed) on ebitda minus spend on intangibles ...and that showed/s where this was/is heading...imv wrt the future ofc ...dyor
Seems the recent seller knew what he/she was doing, I wondered why some sells were well under the current spread at the time !
is setting. I was once in here at 10p.
seems so
As a consequence of continued reductions in OEM revenues and slower than anticipated revenues from the US dealer network, coupled with the Board's strategic decision to reduce inventories within the customer supply chain, it is anticipated that full year revenue and profit will be significantly below market expectations. Furthermore, in light of current trading the Board has concluded that the Group should focus on growth of the SI Brand, cash conversion and those OEM products that add value to the SI Brand. Consequently, the Directors have performed a review of all balance sheet OEM assets resulting in an exceptional non-cash impairment charge of £2.2 million.
Read the rns mate! Expected to be below expectations.
The drop? No news. No volume.
?
Hi. It was directly from their website. Can't see why they are drifting down at the moment unless it's the strengthening pound?
Hi pinto Where did you get this info ?
Tuesday, 5 August, 2014 Surgical Innovations (SI) is pleased to announce that its latest conference appearance in Edinburgh was a resounding success. The IPEG conference (International Pediatric Endosurgery Group) is an internationally renowned organisation for surgeons who specialise in minimal invasive surgery for children and adolescents. This gave SI the opportunity to make a move into the “Ultra” Minimal Invasive Surgery (MIS) market by showing off its newly patented range of 3mm instruments. Throughout the four-day event, SI were able to show off their full range of 3mm products, which have been designed to maintain the accurate performance of the 5mm range, without sacrificing the rigidity required for surgery. “We are continuing to cement strong relationships with the paediatric community around the world. Being at IPEG has certainly confirmed SI’s continued focus on the development of innovative 3mm technology. There are exciting times ahead!” said Katherine Sloggett, Product Marketing Manager. Throughout the exhibition, the product that received the most interest was SI’s 3mm PretzelFlex™. Katherine, added: “It is clear that the technology contributing to PretzelFlex’s innovative design is highly beneficial for paediatric surgery. The strength maintained by the device whilst in use, as well as the small area needed to form the signature Pretzel shape, are key elements that continue to draw the attention of international paediatric surgeons.”
it?
Doesn't look like it......
so drift down towards?
3 reasons I can see :- secured bank funding for new factory, 8% stake bought by local businessman (adding 1.5 million to funds) and new product pipeline. This share reached over 10p not too long ago and has been oversold IMHO (including myself). I bought in again around 4.5p and am hoping for 100% (you can alwys dream!!)
Yes, but why now? What has suddenly clicked?